Recall: D-066-2013

Class II - Potentially Harmful

Class IIClassification

2012-06-29Initiated

TerminatedStatus

Mylan LLC.Firm

Product

Mylan, Tacrolimus Capsules 0.5 mg, 100 count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 NDC 0378-2045-01

Reason

Failed USP Content Uniformity Requirements: OOS result reported on retained samples.

Distribution

Natiowide

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.